Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aidapak Services, LLC is recalling Atorvastatin Calcium 10 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling 10 mg Nortriptyline HCL capsules because they may have been mislabeled as 80 mg Valsartan tablets.
Aidapak Services, LLC is recalling 5 mg Escitalopram tablets because they may have been mislabeled as Sodium Chloride tablets.
Aidapak Services, LLC is recalling 200 mg Mexiletine HCL capsules that may have been mislabeled as 10 mg Isosorbide Dinitrate tablets.
Aidapak Services is recalling repacked progesterone capsules that may be mislabeled as levothyroxine sodium tablets. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling Minocycline HCL capsules that may have been mislabeled as Progesterone. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Guanfacine HC tablets because they may have been mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Levothyroxine Sodium 175 mcg tablets because they may have been mislabeled as other medications.
Aidapak Services is recalling 1 mg Sirolimus tablets that may be mislabeled as Propranolol or Hydrocortisone. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Terbutaline Sulfate 2.5 mg tablets because they may have been mislabeled as Sotalol HCl 80 mg.
Aidapak Services is recalling Perphenazine 16 mg tablets because they may have been mislabeled as other prescription drugs.
Cubist Pharmaceuticals is recalling 179,870 vials of Cubicin (daptomycin for injection) due to the presence of glass particulates.
Aidapak Services, LLC is recalling 5 mg rosuvastatin calcium tablets because they may have been mislabeled as ibuprofen or ascorbic acid.
Aidapak Services, LLC is recalling Thiamine HCL 100 mg tablets because they may have been mislabeled as other drugs, including simvastatin and buprenorphine.
Aidapak Services, LLC is recalling Bismuth Subsalicylate chewable tablets that may have been mislabeled as Irbesartan. The error could lead to patients taking the wrong medication.
Aidapak Services is recalling chlorpromazine HCl tablets that may be mislabeled as acamprosate calcium. The error could lead to patients receiving the wrong medication.
Aidapak Services is recalling Minoxidil 2.5 mg tablets because they may have been mislabeled as methylprednisolone 4 mg.
Aidapak Services, LLC is recalling glyBURIDE tablets that may have been mislabeled as other prescription drugs. The error poses a risk of patients receiving incorrect medication.
Aidapak Services is recalling dexamethasone tablets that may have been mislabeled as venlafaxine capsules.
Aidapak Services is recalling 16 mg Perphenazine tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling 500 mg Ascorbic Acid tablets because they may have been mislabeled as Venlafaxine HCL 100 mg.
Codman & Shurtleff, Inc. is recalling 7,983 units of the TRUFILL n-BCA Liquid Embolic System due to incorrect instructions for use.
Aidapak Services, LLC is recalling methylprednisolone tablets that may have been mislabeled as levothyroxine, nabumetone, or cholecalciferol.
Aidapak Services, LLC is recalling 10 mg Piroxicam capsules because they may have been mislabeled as Hyoscyamine Sulfate. The error could lead to patients receiving the wrong medication.
Aidapak Services is recalling Tri-Buffered Aspirin tablets because they may have been mislabeled as a different medication. The error involves a potential mix-up with Isometheptene Mucate/Dichlorphenazone/APAP capsules.